Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

241
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
241
Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

475
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
475
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

242
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
242
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

520
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
520
Antiepileptic Drugs: Calcium Channel Blockers01:17

Antiepileptic Drugs: Calcium Channel Blockers

537
Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
537
Anxiolytic Drugs: Overview01:26

Anxiolytic Drugs: Overview

429
Anxiolytic drugs are vital in managing anxiety disorders by effectively alleviating symptoms such as excessive fear, tachycardia, and tremors. There are several classes of anxiolytic medications, each with unique mechanisms of action and potential side effects.
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic...
429

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Anhedonic Traits Do Not Impair Performance in a 3-Arm Bandit Task.

Computational psychiatry (Cambridge, Mass.)·2026
Same author

Does having bad epilepsy make you a good surgical candidate? A number needed to treat analysis.

Epilepsia open·2026
Same author

White matter resection and verbal memory deficits after temporal lobe epilepsy surgery.

Brain communications·2026
Same author

The Extremely Brilliant Brain: An Isotropic Microscale Human Brain Dataset.

bioRxiv : the preprint server for biology·2026
Same author

Experiences of ictal OP-MEG.

Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology·2026
Same author

Characterization of Sleep in Alternating Hemiplegia of Childhood: An International Survey.

Neurology. Genetics·2025
Same journal

Assessing cognition and quality of life in people with epilepsy: A feasibility study for mild and marked cognitive impairment.

Epilepsy & behavior : E&B·2026
Same journal

Validating the C-PHQ-9 suicide item against the C-NDDI-E for detecting suicidal ideation in Chinese adults with epilepsy.

Epilepsy & behavior : E&B·2026
Same journal

The IMPACT epilepsy Consortium: Exploring social drivers of health in epilepsy care to advance solution based initiatives.

Epilepsy & behavior : E&B·2026
Same journal

Surgical management of super-refractory status epilepticus (SRSE): a structured narrative review with considerations on refractory status epilepticus (RSE).

Epilepsy & behavior : E&B·2026
Same journal

Sex difference in the association of antiseizure medication load with cognitive decline in older people with epilepsy: A prospective study.

Epilepsy & behavior : E&B·2026
Same journal

Improving epilepsy knowledge, attitudes & practices among primary health care providers: findings from a pre-post intervention study in Central India.

Epilepsy & behavior : E&B·2026
See all related articles

Related Experiment Video

Updated: Aug 19, 2025

Using a Bipolar Electrode to Create a Temporal Lobe Epilepsy Mouse Model by Electrical Kindling of the Amygdala
09:49

Using a Bipolar Electrode to Create a Temporal Lobe Epilepsy Mouse Model by Electrical Kindling of the Amygdala

Published on: June 29, 2022

2.6K

Anhedonia in epilepsy.

Lucy Roberts-West1, Umesh Vivekananda2, Sallie Baxendale2

  • 1University College Hospital, London, United Kingdom.

Epilepsy & Behavior : E&B
|November 28, 2022
PubMed
Summary
This summary is machine-generated.

Anhedonia, the inability to feel pleasure, affects over a third of people with epilepsy. This symptom can occur even without depression, and may be linked to cognitive impairments like poor memory.

Keywords:
AnhedoniaAnxietyCognitive functionDepressionFocal epilepsyMemory

More Related Videos

Microdialysis of Excitatory Amino Acids During EEG Recordings in Freely Moving Rats
08:47

Microdialysis of Excitatory Amino Acids During EEG Recordings in Freely Moving Rats

Published on: November 8, 2018

11.5K
Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice
07:01

Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice

Published on: May 16, 2019

9.1K

Related Experiment Videos

Last Updated: Aug 19, 2025

Using a Bipolar Electrode to Create a Temporal Lobe Epilepsy Mouse Model by Electrical Kindling of the Amygdala
09:49

Using a Bipolar Electrode to Create a Temporal Lobe Epilepsy Mouse Model by Electrical Kindling of the Amygdala

Published on: June 29, 2022

2.6K
Microdialysis of Excitatory Amino Acids During EEG Recordings in Freely Moving Rats
08:47

Microdialysis of Excitatory Amino Acids During EEG Recordings in Freely Moving Rats

Published on: November 8, 2018

11.5K
Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice
07:01

Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice

Published on: May 16, 2019

9.1K

Area of Science:

  • Neurology
  • Psychiatry

Background:

  • Anhedonia is a core symptom of major depressive disorder and a feature in other neurological conditions.
  • Epilepsy frequently co-occurs with depression, raising questions about anhedonia's prevalence in this population.
  • The study investigates anhedonia in epilepsy, both with and without comorbid depression.

Purpose of the Study:

  • To determine the prevalence of anhedonia in individuals with epilepsy.
  • To explore the relationship between anhedonia and depression in epilepsy patients.
  • To examine clinical and demographic factors associated with anhedonia in epilepsy.

Main Methods:

  • A sample of 211 epilepsy patients completed the Snaith-Hamilton Pleasure Scale (SHAPS) and the Hospital Anxiety and Depression Scale.
  • Patients were assessed for focal, generalized, or unclassified epilepsy.
  • The study recorded clinical diagnoses of depression.

Main Results:

  • 35% of the epilepsy sample reported significant anhedonia.
  • Anhedonia was more common in patients with depression (p < 0.01), but 30% of those without depression also experienced it.
  • Anhedonia correlated with cognitive difficulties, particularly impaired memory function.

Conclusions:

  • Anhedonia is prevalent in epilepsy, occurring in up to one-third of patients without depression.
  • Cognitive deficits, especially memory impairment, may contribute to anhedonia in epilepsy.
  • Findings suggest implications for managing anhedonia in epilepsy patients, considering cognitive factors.